Skip to main content
Top

Drugs

Issue 13/2017

Content (9 Articles)

Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook

  • Leading Article

Jusleen Ahluwalia, Jeremy Udkoff, Andrea Waldman, Jenna Borok, Lawrence F. Eichenfield

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects

  • Therapy in Practice

Garyphallia Poulakou, Dimitrios K. Matthaiou, David P. Nicolau, Georgios Siakallis, George Dimopoulos

Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review

  • Review Article

Selene R. T. Veerman, Peter F. J. Schulte, Lieuwe de Haan

Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases

  • Open Access
  • Original Research Article

Y. Schuller, C. E. M. Hollak, C. C. Gispen-de Wied, V. Stoyanova-Beninska, M. Biegstraaten

Delafloxacin: First Global Approval

  • Open Access
  • AdisInsight Report

Anthony Markham

Guselkumab: First Global Approval

  • AdisInsight Report

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images